- Home
- CELZ vs POAI Comparison
CELZ vs POAI Comparison
Compare CELZ & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- POAI
- Stock Information
- Founded
- CELZ 1998
- POAI 2002
- Country
- CELZ United States
- POAI United States
- Employees
- CELZ N/A
- POAI N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- POAI Industrial Specialties
- Sector
- CELZ Health Care
- POAI Health Care
- Exchange
- CELZ Nasdaq
- POAI Nasdaq
- Market Cap
- CELZ 7.4M
- POAI 7.8M
- IPO Year
- CELZ N/A
- POAI N/A
- Fundamental
- Price
- CELZ $3.12
- POAI $0.86
- Analyst Decision
- CELZ
- POAI Hold
- Analyst Count
- CELZ 0
- POAI 1
- Target Price
- CELZ N/A
- POAI N/A
- AVG Volume (30 Days)
- CELZ 158.4K
- POAI 213.0K
- Earning Date
- CELZ 08-08-2025
- POAI 08-13-2025
- Dividend Yield
- CELZ N/A
- POAI N/A
- EPS Growth
- CELZ N/A
- POAI N/A
- EPS
- CELZ N/A
- POAI N/A
- Revenue
- CELZ $6,000.00
- POAI $1,664,696.00
- Revenue This Year
- CELZ N/A
- POAI $486.27
- Revenue Next Year
- CELZ N/A
- POAI $65.50
- P/E Ratio
- CELZ N/A
- POAI N/A
- Revenue Growth
- CELZ N/A
- POAI 71.65
- 52 Week Low
- CELZ $1.69
- POAI $0.55
- 52 Week High
- CELZ $6.90
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- CELZ 54.15
- POAI 57.84
- Support Level
- CELZ $2.75
- POAI $0.71
- Resistance Level
- CELZ $3.36
- POAI $0.94
- Average True Range (ATR)
- CELZ 0.34
- POAI 0.06
- MACD
- CELZ -0.00
- POAI 0.01
- Stochastic Oscillator
- CELZ 37.59
- POAI 62.70
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.